COVID Vaccine Initiative

The COVID Vaccine Initiative (CVI) aims to ensure the development of safe, effective, and accessible vaccines for those most vulnerable to COVID-19: aging populations and those living in low- and middle-income countries. It leverages HVP’s global clinical research consortium, including newly established collaborations with the Harvard T.H. Chan School of Public Health focused on deciphering effective immunity in aging populations; FHI 360, a global nonprofit research and human development organization with extensive experience working in low and middle-income countries; and the University of Minnesota’s Center for Infectious Disease Research and Policy, a global leader in addressing public health preparedness and emerging infectious disease response.

COVID Newsroom

Global COVID Lab Meeting

Nov 19, 2020

Eleanor N. Fish, Ph.D., F.A.A.S

University of Toronto

Global COVID Lab Meeting

Nov 17, 2020

Vaccine Hesitancy

Harvard T.H. Chan School of Public Health

Global COVID Lab Meeting

Nov 05, 2020

Kizzmekia Corbett, Ph.D.

National Institutes of Health, Allergy and Infectious Diseases, Vaccine Research Center

Global COVID Lab Meeting

Oct 29, 2020

Davide Corti

Vir Biotechnology